Peter Vandenabeele
scientist
medical science
Flanders Interuniversity Institute for Biotechnology
Belgium
Biography
PhD: Ghent University, Belgium, 1990 VIB Group leader since 1996
Research Interest
Inflammation and immunity Cancer Proteomics
Publications
-
Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice Vanden Berghe T, Hulpiau P, Martens L, Vandenbroucke R, Van Wonterghem E, Perry S, Bruggeman I, Divert T, Choi S, Vuylsteke M, Shestopalov V, Libert C, Vandenabeele PIMMUNITY, 43, 200-9, 2015
-
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity Aaes T Kaczmarek A Delvaeye T De Craene B De Koker S Heyndrickx L Delrue I Taminau J Wiernicki B De Groote P Garg A Leybaert L Grooten J Bertrand M Agostinis P Berx G Declercq W Vandenabeele P* Krysko D*Cell Reports, 15, 274-287, 2016
-
Elevated DeltaNp63alpha Levels Facilitate Epidermal and Biliary Oncogenic Transformation Devos M, Gilbert B, Denecker G, Leurs K, McGuire C, Lemeire K, Hochepied T, Vuylsteke M, Lambert J, Van Den Broecke C, Libbrecht L, Haigh J, Berx G, Lippens S, Vandenabeele P, Declercq WJOURNAL OF INVESTIGATIVE DERMATOLOGY, 137, 494-505, 2017